Genprex GNPX
NASDAQ GNPX
$2.63 +0.07 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Genprex (GNPX) Cost of Revenue (2024 - 2025)

Updated

Genprex's Cost of Revenue came in at $483,065 for Q1 2025, down 37.4% from $772,118 a year earlier.

Analysis

Genprex (GNPX) Cost of Revenue (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Genprex 1.33 Mn -40.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 483,065.00
Mar 31, 2024 772,118.00
API Access

Genprex Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GNPX&period=max&api_key=YOUR_API_KEY